Post-Traumatic Stress Disorder (PTSD) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2018-2020 - ResearchAndMarkets.com
Aug. 29, 2018
DUBLIN--(BUSINESS WIRE)--Aug 29, 2018--The "Post-Traumatic Stress Disorder (PTSD) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2018" drug pipelines has been added to ResearchAndMarkets.com's offering.
Post-Traumatic Stress Disorder (PTSD) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2018 report provides comprehensive insights about marketed and Phase III products for Post-Traumatic Stress Disorder (PTSD). The report includes information of marketed products including their product description, patent details, forecasted sales till 2020 & API manufacturer details by country.
Coverage of API manufacturers for Post-Traumatic Stress Disorder (PTSD) marketed products spanning across United States, Europe, China and India. The manufacturers' details include manufacturers' names along with their locations.
This report provides a comprehensive understanding of the emerging Phase III therapies for Post-Traumatic Stress Disorder (PTSD) which can turn out to be future prospective competitors for the marketed products. It will also put light on the current market trends. Their forecasted global sales are also provided till 2020.
Key Topics Covered:
1. Report Introduction
2. Post-Traumatic Stress Disorder (PTSD): OverviewRisk Factors Causes Symptoms Pathophysiology Prognosis Diagnosis Treatment
3. Comparative Analysis of Marketed and Emerging Products
4. Marketed TherapiesProduct Description Route of Synthesis Mechanism of Action Pharmacology Pharmacodynamics Pharmacokinetics Adverse Reactions Clinical Trials Regulatory Milestones Product Development Activities
5. Emerging Therapies (Phase III)Product Description Research and Development Product Development Activities
For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/bfhjwz/posttraumatic?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20180829005700/en/
Laura Wood, Senior Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics:Mental Health,Mental Disorders Drugs
INDUSTRY KEYWORD: HEALTH MENTAL HEALTH PHARMACEUTICAL
SOURCE: Research and Markets
Copyright Business Wire 2018.
PUB: 08/29/2018 03:12 PM/DISC: 08/29/2018 03:12 PM